Yun Long Selected Research

Apolipoproteins E (ApoE)

5/2021

Silencing HIF-1α aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-α/ANGPTL4 singling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yun Long Research Topics

Disease

25	Sepsis (Septicemia) 05/2022 - 12/2002
20	Septic Shock (Toxic Shock Syndrome) 01/2022 - 06/2007
19	Critical Illness (Critically Ill) 05/2022 - 04/2003
9	Infections 01/2021 - 04/2003
7	Shock 01/2021 - 02/2012
6	Hypoxia (Hypoxemia) 05/2021 - 05/2015
5	Lung Injury 10/2021 - 08/2012
5	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021 - 08/2012
4	Hyperlactatemia 01/2021 - 09/2011
3	Inflammation (Inflammations) 05/2021 - 01/2018
3	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 06/2019
3	Endotoxemia 01/2021 - 12/2017
3	Neoplasms (Cancer) 01/2021 - 05/2012
3	Hemorrhage 01/2021 - 09/2018
3	Dyspnea (Shortness of Breath) 01/2021 - 05/2015
3	Thrombosis (Thrombus) 06/2020 - 10/2014
3	Thrombocytopenia (Thrombopenia) 01/2020 - 10/2014
2	Hemorrhagic Shock 05/2022 - 02/2022
2	Ventilator-Associated Pneumonia 05/2022 - 03/2020
2	Respiratory Insufficiency (Respiratory Failure) 10/2021 - 01/2021
2	Hypotension (Low Blood Pressure) 02/2021 - 03/2008
2	Endometrial Neoplasms (Endometrial Cancer) 01/2019 - 10/2017
2	Wounds and Injuries (Trauma) 12/2018 - 09/2018
2	Renal Insufficiency (Renal Failure) 09/2018 - 04/2016
2	Invasive Pulmonary Aspergillosis 05/2017 - 03/2009
2	Cardiogenic Shock 04/2016 - 10/2015
2	Bacteremia 01/2016 - 12/2002
2	Pheochromocytoma 05/2015 - 03/2008
1	Urinary Tract Infections (Urinary Tract Infection) 05/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Fistula 01/2022
1	Enterocolitis 01/2022
1	Intestinal Perforation 01/2022
1	Hyperventilation 12/2021
1	Hyperthyroidism 09/2021
1	Neck Pain (Cervicalgia) 09/2021
1	Coronary Disease (Coronary Heart Disease) 09/2021
1	Non-alcoholic Fatty Liver Disease 05/2021

Drug/Important Bio-Agent (IBA)

9	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 04/2003
6	Carbon DioxideIBA 12/2021 - 04/2012
6	Oxygen (Dioxygen)IBA 05/2021 - 09/2011
6	Lactic Acid (Lactate)FDA LinkGeneric 02/2021 - 09/2011
4	Pharmaceutical PreparationsIBA 09/2021 - 03/2014
4	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2021 - 03/2008
4	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 10/2014
3	Interleukin-6 (Interleukin 6)IBA 05/2021 - 05/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 09/2021
2	GlucocorticoidsIBA 01/2022 - 01/2015
2	ProcalcitoninIBA 01/2022 - 10/2017
2	Hypnotics and Sedatives (Sedatives)IBA 09/2021 - 01/2021
2	Analgesics (Analgesic Drugs)IBA 09/2021 - 01/2021
2	LipidsIBA 05/2021 - 01/2019
2	AntioxidantsIBA 05/2021 - 08/2013
2	Transcription Factors (Transcription Factor)IBA 05/2021 - 05/2017
2	Oleic Acid (Oleate)IBA 05/2021 - 08/2012
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 04/2019
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
2	Indicators and Reagents (Reagents)IBA 09/2020 - 09/2020
2	TOR Serine-Threonine KinasesIBA 12/2019 - 05/2017
2	MicroRNAs (MicroRNA)IBA 01/2019 - 10/2017
2	Adenosine Triphosphate (ATP)IBA 12/2018 - 03/2015
2	LipopolysaccharidesIBA 12/2018 - 01/2018
2	esmolol (Brevibloc)FDA LinkGeneric 12/2017 - 07/2016
2	CatecholaminesIBA 05/2015 - 03/2008
2	CyclinsIBA 08/2011 - 06/2009
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 05/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2022
1	pembrolizumabIBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	MetalsIBA 09/2021
1	Antithyroid Agents (Antithyroid Drugs)IBA 09/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2021
1	Apolipoproteins E (ApoE)IBA 05/2021
1	Apolipoproteins B (ApoB)IBA 05/2021
1	Triglycerides (Triacylglycerol)IBA 05/2021
1	ApolipoproteinsIBA 05/2021
1	EnzymesIBA 05/2021
1	Palmitic Acid (Hexadecanoic Acid)IBA 05/2021
1	pyrrolidin-3-yl-methanesulfonic acid (PMSA)IBA 04/2021
1	Crystalloid SolutionsIBA 02/2021
1	Thromboplastin (Tissue Factor)IBA 01/2021

Therapy/Procedure

17	Resuscitation 02/2021 - 02/2010
12	Therapeutics 01/2022 - 04/2014
9	Artificial Respiration (Mechanical Ventilation) 10/2021 - 01/2019
7	Critical Care (Surgical Intensive Care) 05/2022 - 01/2019
7	Mechanical Ventilators (Ventilator) 10/2021 - 04/2016
5	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2021 - 08/2012
4	Extracorporeal Membrane Oxygenation 01/2021 - 05/2015
3	Ligation 08/2013 - 06/2009
3	Punctures 08/2013 - 06/2009
2	Catheters 05/2022 - 09/2020
2	Fluid Therapy (Oral Rehydration Therapy) 01/2022 - 01/2016
2	Length of Stay 01/2022 - 01/2021
2	Anesthesia 01/2021 - 08/2009
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2021 - 06/2019
2	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2020 - 10/2017
1	Immunotherapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Stents 09/2021
1	Parenteral Nutrition 01/2021